These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs. Morio Y; Homma N; Takahashi H; Yamamoto A; Nagaoka T; Sato K; Muramatsu M; Fukuchi Y J Vasc Res; 2007; 44(4):325-35. PubMed ID: 17438361 [TBL] [Abstract][Full Text] [Related]
9. The vasoactive intestinal peptide gene is a key modulator of pulmonary vascular remodeling and inflammation. Said SI Ann N Y Acad Sci; 2008 Nov; 1144():148-53. PubMed ID: 19076374 [TBL] [Abstract][Full Text] [Related]
10. Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Xu W; Koeck T; Lara AR; Neumann D; DiFilippo FP; Koo M; Janocha AJ; Masri FA; Arroliga AC; Jennings C; Dweik RA; Tuder RM; Stuehr DJ; Erzurum SC Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1342-7. PubMed ID: 17227868 [TBL] [Abstract][Full Text] [Related]
11. Primary pulmonary arterial hypertension: a look back. Fishman AP J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):2S-4S. PubMed ID: 15194172 [TBL] [Abstract][Full Text] [Related]
12. Pathology of pulmonary hypertension. Voelkel NF; Cool C Cardiol Clin; 2004 Aug; 22(3):343-51, v. PubMed ID: 15302355 [TBL] [Abstract][Full Text] [Related]
13. Current insights on the pathogenesis of pulmonary arterial hypertension. Perros F; Dorfmüller P; Humbert M Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311 [TBL] [Abstract][Full Text] [Related]
15. [Endothelial ion channels -- novel targets for antihypertensive therapy]. Maier T; Grgic I; Busch C; Hoyer J; Köhler R Dtsch Med Wochenschr; 2005 Nov; 130(46):2637-9. PubMed ID: 16281159 [TBL] [Abstract][Full Text] [Related]
16. Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension. Zhao Q; Liu Z; Wang Z; Yang C; Liu J; Lu J Ann Thorac Surg; 2007 Aug; 84(2):544-52. PubMed ID: 17643632 [TBL] [Abstract][Full Text] [Related]
17. Pathologic assessment of vasculopathies in pulmonary hypertension. Pietra GG; Capron F; Stewart S; Leone O; Humbert M; Robbins IM; Reid LM; Tuder RM J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):25S-32S. PubMed ID: 15194175 [TBL] [Abstract][Full Text] [Related]
18. [Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension]. Ghofrani HA; Schermuly RT; Weissmann N; Seeger W; Grimminger F Dtsch Med Wochenschr; 2006 Apr; 131(16):871-4. PubMed ID: 16625479 [No Abstract] [Full Text] [Related]
19. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929 [TBL] [Abstract][Full Text] [Related]
20. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering. Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]